Consistent with CPT being an effective therapeutic in treating advanced colon cancer in the clinic is the finding that TOP1 is significantly up-regulated in COAD tumors and high TOP1 expression is associated with high CPT sensitivity (29, 30). Here, TOP1 is linked to colon adenocarcinoma.